Literature DB >> 11553014

Evidence of a leading role for VEGF in Bartonella henselae-induced endothelial cell proliferations.

V A Kempf1, B Volkmann, M Schaller, C A Sander, K Alitalo, T Riess, I B Autenrieth.   

Abstract

Bartonella henselae causes the vasculoproliferative disorders bacillary angiomatosis (BA) and bacillary peliosis (BP). The pathomechanisms of these tumorous proliferations are unknown. Our results suggest a novel bacterial two-step pathogenicity strategy, in which the pathogen triggers growth factor production for subsequent proliferation of its own host cells. In fact, B. henselae induces host cell production of the angiogenic factor vascular endothelial growth factor (VEGF), leading to proliferation of endothelial cells. The presence of B. henselae pili was associated with host cell VEGF production, as a Pil- mutant of B. henselae was unable to induce VEGF production. In turn, VEGF-stimulated endothelial cells promoted the growth of B. henselae. Immunohistochemistry for VEGF in specimens from patients with BA or BP revealed increased VEGF expression in vivo. These findings suggest a novel bacteria-dependent mechanism of tumour growth.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11553014     DOI: 10.1046/j.1462-5822.2001.00144.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  53 in total

1.  Heterologous expression of Bartonella adhesin A in Escherichia coli by exchange of trimeric autotransporter adhesin domains results in enhanced adhesion properties and a pathogenic phenotype.

Authors:  Thomas Schmidgen; Patrick O Kaiser; Wibke Ballhorn; Bettina Franz; Stephan Göttig; Dirk Linke; Volkhard A J Kempf
Journal:  J Bacteriol       Date:  2014-03-28       Impact factor: 3.490

2.  Interaction of Bartonella henselae with endothelial cells promotes monocyte/macrophage chemoattractant protein 1 gene expression and protein production and triggers monocyte migration.

Authors:  Amy M McCord; Andrew W O Burgess; Melissa J Whaley; Burt E Anderson
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  Bartonella species as a potential cause of epistaxis in dogs.

Authors:  Edward B Breitschwerdt; Barbara C Hegarty; Ricardo Maggi; Eleanor Hawkins; Page Dyer
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

Review 4.  Breaking the wall: targeting of the endothelium by pathogenic bacteria.

Authors:  Emmanuel Lemichez; Marc Lecuit; Xavier Nassif; Sandrine Bourdoulous
Journal:  Nat Rev Microbiol       Date:  2009-12-30       Impact factor: 60.633

5.  Zebrafish embryo model of Bartonella henselae infection.

Authors:  Amorce Lima; Byeong J Cha; Jahanshah Amin; Lisa K Smith; Burt Anderson
Journal:  Zebrafish       Date:  2014-07-15       Impact factor: 1.985

6.  Analysis of Bartonella adhesin A expression reveals differences between various B. henselae strains.

Authors:  Tanja Riess; Günter Raddatz; Dirk Linke; Andrea Schäfer; Volkhard A J Kempf
Journal:  Infect Immun       Date:  2006-10-23       Impact factor: 3.441

7.  An immunocompromised murine model of chronic Bartonella infection.

Authors:  Lucius Chiaraviglio; Scott Duong; Daniel A Brown; Richard J Birtles; James E Kirby
Journal:  Am J Pathol       Date:  2010-04-15       Impact factor: 4.307

8.  Bartonella species bacteremia in two patients with epithelioid hemangioendothelioma.

Authors:  Patricia E Mascarelli; Jonathan R Iredell; Ricardo G Maggi; Guy Weinberg; Edward B Breitschwerdt
Journal:  J Clin Microbiol       Date:  2011-09-14       Impact factor: 5.948

9.  Bartonella bacilliformis GroEL: effect on growth of human vascular endothelial cells in infected cocultures.

Authors:  Laura S Smitherman; Michael F Minnick
Journal:  Ann N Y Acad Sci       Date:  2005-12       Impact factor: 5.691

Review 10.  Infection-associated type IV secretion systems of Bartonella and their diverse roles in host cell interaction.

Authors:  Christoph Dehio
Journal:  Cell Microbiol       Date:  2008-07-30       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.